247 related articles for article (PubMed ID: 25593236)
1. Incidence of malignancy and the risk of lymphoma in Japanese patients with rheumatoid arthritis compared to the general population.
Hashimoto A; Chiba N; Tsuno H; Komiya A; Furukawa H; Matsui T; Nishino J; Tohma S
J Rheumatol; 2015 Apr; 42(4):564-71. PubMed ID: 25593236
[TBL] [Abstract][Full Text] [Related]
2. Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate.
Buchbinder R; Barber M; Heuzenroeder L; Wluka AE; Giles G; Hall S; Harkness A; Lewis D; Littlejohn G; Miller MH; Ryan PF; Jolley D
Arthritis Rheum; 2008 Jun; 59(6):794-9. PubMed ID: 18512713
[TBL] [Abstract][Full Text] [Related]
3. Do rheumatoid arthritis and lymphoma share risk factors?: a comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis.
Hellgren K; Smedby KE; Feltelius N; Baecklund E; Askling J
Arthritis Rheum; 2010 May; 62(5):1252-8. PubMed ID: 20155827
[TBL] [Abstract][Full Text] [Related]
4. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients.
Wolfe F; Michaud K
Arthritis Rheum; 2004 Jun; 50(6):1740-51. PubMed ID: 15188349
[TBL] [Abstract][Full Text] [Related]
5. Risk for malignancy in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs compared to the general population: A nationwide cohort study in Japan.
Harigai M; Nanki T; Koike R; Tanaka M; Watanabe-Imai K; Komano Y; Sakai R; Yamazaki H; Koike T; Miyasaka N
Mod Rheumatol; 2016 Sep; 26(5):642-50. PubMed ID: 26873430
[TBL] [Abstract][Full Text] [Related]
6. Incidence of malignancy in Japanese patients with rheumatoid arthritis.
Yamada T; Nakajima A; Inoue E; Tanaka E; Taniguchi A; Momohara S; Yamanaka H
Rheumatol Int; 2011 Nov; 31(11):1487-92. PubMed ID: 20473757
[TBL] [Abstract][Full Text] [Related]
7. The age-risk relationship of hematologic malignancies in patients with rheumatoid arthritis: a nationwide retrospective cohort study.
Lin YC; Chou HW; Tsai WC; Yen JH; Chang SJ; Lin YC
Clin Rheumatol; 2015 Jul; 34(7):1195-202. PubMed ID: 25990004
[TBL] [Abstract][Full Text] [Related]
8. Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis.
Simon TA; Thompson A; Gandhi KK; Hochberg MC; Suissa S
Arthritis Res Ther; 2015 Aug; 17(1):212. PubMed ID: 26271620
[TBL] [Abstract][Full Text] [Related]
9. Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a South European population.
Abásolo L; Júdez E; Descalzo MA; González-Alvaro I; Jover JA; Carmona L;
Semin Arthritis Rheum; 2008 Jun; 37(6):388-97. PubMed ID: 17977580
[TBL] [Abstract][Full Text] [Related]
10. Risk of malignancy among patients with rheumatic conditions.
Thomas E; Brewster DH; Black RJ; Macfarlane GJ
Int J Cancer; 2000 Nov; 88(3):497-502. PubMed ID: 11054684
[TBL] [Abstract][Full Text] [Related]
11. Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists.
Askling J; Fored CM; Baecklund E; Brandt L; Backlin C; Ekbom A; Sundström C; Bertilsson L; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Klareskog L; Feltelius N
Ann Rheum Dis; 2005 Oct; 64(10):1414-20. PubMed ID: 15843454
[TBL] [Abstract][Full Text] [Related]
12. [Biologics and mycobacterial diseases].
Tsuyuguchi K; Matsumoto T
Kekkaku; 2013 Mar; 88(3):337-53. PubMed ID: 23672175
[TBL] [Abstract][Full Text] [Related]
13. The Risk of Malignancy in Korean Patients with Rheumatoid Arthritis.
Lee H
Yonsei Med J; 2019 Feb; 60(2):223-229. PubMed ID: 30666845
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the malignancy incidence among patients with psoriatic arthritis and patients with rheumatoid arthritis in a large US cohort.
Gross RL; Schwartzman-Morris JS; Krathen M; Reed G; Chang H; Saunders KC; Fisher MC; Greenberg JD; Putterman C; Mease PJ; Gottlieb AB; Kremer JM; Broder A
Arthritis Rheumatol; 2014 Jun; 66(6):1472-81. PubMed ID: 24591475
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, incidence, and risk factors of malignancy in patients with rheumatoid arthritis: a nationwide cohort study from Korea.
Ko KM; Moon SJ
Korean J Intern Med; 2023 Jan; 38(1):113-124. PubMed ID: 34407599
[TBL] [Abstract][Full Text] [Related]
16. Rheumatoid arthritis and the risk of malignancy.
Cibere J; Sibley J; Haga M
Arthritis Rheum; 1997 Sep; 40(9):1580-6. PubMed ID: 9324011
[TBL] [Abstract][Full Text] [Related]
17. How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries.
Askling J; Berglind N; Franzen S; Frisell T; Garwood C; Greenberg JD; Ho M; Holmqvist M; Horne L; Inoue E; Michaud K; Nyberg F; Pappas DA; Reed G; Tanaka E; Tran TN; Verstappen SM; Yamanaka H; Wesby-van Swaay E; Symmons D
Ann Rheum Dis; 2016 Oct; 75(10):1789-96. PubMed ID: 26621482
[TBL] [Abstract][Full Text] [Related]
18. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives.
Ekström K; Hjalgrim H; Brandt L; Baecklund E; Klareskog L; Ekbom A; Askling J
Arthritis Rheum; 2003 Apr; 48(4):963-70. PubMed ID: 12687538
[TBL] [Abstract][Full Text] [Related]
19. Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study.
Wolfe F; Michaud K
Arthritis Rheum; 2007 Sep; 56(9):2886-95. PubMed ID: 17729297
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis.
Smitten AL; Simon TA; Hochberg MC; Suissa S
Arthritis Res Ther; 2008; 10(2):R45. PubMed ID: 18433475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]